Immunogen Inc (IMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 113,425 | 83,153 | 49,869 | 41,167 | 15,375 |
| Cost of Goods | 2,155 | 909 | 626 | N/A | N/A |
| Gross Profit | 111,270 | 82,244 | 49,243 | 40,991 | 15,375 |
| Operating Expenses | 85,469 | 87,342 | 92,262 | 100,726 | 92,804 |
| Operating Income | 25,956 | -4,189 | -42,393 | -59,559 | -77,429 |
| Interest Expense | 3,593 | 4,397 | 853 | 971 | 867 |
| Other Income | 7,219 | 5,215 | 2,232 | 2,740 | 541 |
| Pre-tax Income | 29,582 | -3,371 | -41,014 | -57,790 | -77,755 |
| Income Tax | -1,166 | 877 | N/A | N/A | 0 |
| Net Income Continuous | 30,748 | -4,248 | -41,014 | -59,008 | -77,755 |
| Net Income | $30,748 | $-4,248 | $-41,014 | $-59,008 | $-77,755 |
| EPS Basic Total Ops | 0.10 | -0.02 | -0.16 | -0.23 | -0.31 |
| EPS Basic Continuous Ops | 0.11 | -0.02 | -0.16 | -0.23 | -0.31 |
| EPS Diluted Total Ops | 0.10 | -0.02 | -0.16 | -0.23 | -0.31 |
| EPS Diluted Continuous Ops | 0.11 | -0.02 | -0.16 | -0.23 | -0.31 |
| EPS Diluted Before Non-Recurring Items | 0.10 | -0.02 | -0.16 | -0.23 | -0.31 |
| EBITDA(a) | $26,379 | $-3,762 | $-41,945 | $-59,131 | $-77,005 |